InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by DeVinney Erick Wayne, Vice-Président. Officer active across 1 companies, notably Axogen, Inc.. In total, 10 disclosures have been logged. The latest transaction was filed on 16 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
06,000 shares0
Common Stock
SEC:0000805928-22-000028:0·
01,181 shares0
Common Stock
SEC:0000805928-22-000008:0·
0750 shares0
Common Stock
SEC:0000805928-21-000179·
0750 shares0
Common Stock
SEC:0000805928-21-000179:0·
0575 shares0
Common Stock
SEC:0000805928-21-000173·
0575 shares0
Common Stock
SEC:0000805928-21-000173:0·
€32,59010,000 shares@ €3.2590.0021% mcap100.0% of flow
Common Stock
SEC:0000805928-21-000172·
€32,59010,000 shares@ €3.2590.0021% mcap50.0% of flow
Common Stock
SEC:0000805928-21-000172:0·
01,580 shares0
Common Stock
SEC:0000805928-21-000148·
01,580 shares0
Common Stock
SEC:0000805928-21-000148:0·
10 of 10 declarations
About DeVinney Erick Wayne
Erick Wayne DeVinney serves as the Vice President of Peripheral Nerve Science at Axogen, Inc. In this role, he oversees operations related to research and development of innovative solutions for peripheral nerves. DeVinney contributes to the advancement of medical technologies within the company.
